Studies in the Human Frontal Cortex: Evidence for Changes in Neurochemical Markers in Schizophrenia and Bipolar Disorder
Reference49 articles.
1. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, and Lewis DA. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. A J Psychiatry 1999; 156: 1580–1589.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Forth edition). American Psychiatric Association, Washington, D.C., 1994.
3. Andrews G, Hall W, Goldstein G, Lapsley H, Bartels R, and Silove D. The economic costs of schizophrenia. Implications for public policy. Arch Gen Psychiatry 1985; 42: 537–543.
4. Arora RC and Meltzer HY. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 1991; 85: 19–29.
5. Avissar S, Schreiber G, Aulakh CS, Wozniak KM, and Murphy DL. Carbamazepine and electroconvulsive shock attenuate beta-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex. Eur J Pharmacol 1990; 189: 99–103.